 | • レポートコード：QY2108PAL4052 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はベラパミルの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ベラパミルの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（錠剤、カプセル、注射、その他）、用途別市場規模（病院薬局、小売薬局、オンライン販売、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ベラパミルの世界市場概要 ・メーカー別の競争状況、市場シェア ・ベラパミルの種類別市場規模：錠剤、カプセル、注射、その他 ・ベラパミルの用途別市場規模：病院薬局、小売薬局、オンライン販売、その他 ・北米のベラパミル市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのベラパミル市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのベラパミル市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のベラパミル市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのベラパミル市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：REPLEK FARM、Mylan、Abbott Laboratories、YUNGSHIN PHARM IND. CO. LTD、The Central Pharmaceutical CO.,Ltd.Tianjin ・ベラパミルのバリューチェーン・販売チャネル分析 ・ベラパミルの世界市場動向 |
Verapamil is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Verapamil belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily.Verapamil is also used to prevent chest pain (angina). It may help to increase your ability to exercise and decrease how often you may get angina attacks. Verapamil is also used to control your heart rate if you have a fast/irregular heartbeat (such as atrial fibrillation). It helps to lower the heart rate, helping you to feel more comfortable and increase your ability to exercise.
Market Analysis and Insights: Global Verapamil Market
The global Verapamil market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Verapamil Scope and Segment
Verapamil market is segmented by Type, and by Sales Channel. Players, stakeholders, and other participants in the global Verapamil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2016-2027.
Segment by Type
Tablets
Capsules
Injection
Others
Segment by Sales Channel
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others
By Company
REPLEK FARM
Mylan
Abbott Laboratories
YUNGSHIN PHARM IND. CO. LTD
The Central Pharmaceutical CO.,Ltd.Tianjin
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Verapamil Product Introduction
1.2 Market by Type
1.2.1 Global Verapamil Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Injection
1.2.5 Others
1.3 Market by Sales Channel
1.3.1 Global Verapamil Market Size Growth Rate by Sales Channel
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Verapamil Sales Estimates and Forecasts 2016-2027
2.2 Global Verapamil Revenue Estimates and Forecasts 2016-2027
2.3 Global Verapamil Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Verapamil Regions by Sales
2.4.1 Global Top Verapamil Regions by Sales (2016-2021)
2.4.2 Global Top Verapamil Regions by Sales (2022-2027)
2.5 Global Top Verapamil Regions by Revenue
2.5.1 Global Top Verapamil Regions by Revenue (2016-2021)
2.5.2 Global Top Verapamil Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Verapamil Sales by Manufacturers
3.1.1 Global Top Verapamil Manufacturers by Sales (2016-2021)
3.1.2 Global Top Verapamil Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Verapamil Sales in 2020
3.2 Global Verapamil Revenue by Manufacturers
3.2.1 Global Top Verapamil Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Verapamil Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Verapamil Revenue in 2020
3.3 Global Verapamil Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Verapamil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Verapamil Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Verapamil Sales by Type
4.1.1 Global Verapamil Historical Sales by Type (2016-2021)
4.1.2 Global Verapamil Forecasted Sales by Type (2022-2027)
4.1.3 Global Verapamil Sales Market Share by Type (2016-2027)
4.2 Global Verapamil Revenue by Type
4.2.1 Global Verapamil Historical Revenue by Type (2016-2021)
4.2.2 Global Verapamil Forecasted Revenue by Type (2022-2027)
4.2.3 Global Verapamil Revenue Market Share by Type (2016-2027)
4.3 Global Verapamil Price by Type
4.3.1 Global Verapamil Price by Type (2016-2021)
4.3.2 Global Verapamil Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Verapamil Sales by Sales Channel
5.1.1 Global Verapamil Historical Sales by Sales Channel (2016-2021)
5.1.2 Global Verapamil Forecasted Sales by Sales Channel (2022-2027)
5.1.3 Global Verapamil Sales Market Share by Sales Channel (2016-2027)
5.2 Global Verapamil Revenue by Sales Channel
5.2.1 Global Verapamil Historical Revenue by Sales Channel (2016-2021)
5.2.2 Global Verapamil Forecasted Revenue by Sales Channel (2022-2027)
5.2.3 Global Verapamil Revenue Market Share by Sales Channel (2016-2027)
5.3 Global Verapamil Price by Sales Channel
5.3.1 Global Verapamil Price by Sales Channel (2016-2021)
5.3.2 Global Verapamil Price Forecast by Sales Channel (2022-2027)
6 North America
6.1 North America Verapamil Market Size by Type
6.1.1 North America Verapamil Sales by Type (2016-2027)
6.1.2 North America Verapamil Revenue by Type (2016-2027)
6.2 North America Verapamil Market Size by Sales Channel
6.2.1 North America Verapamil Sales by Sales Channel (2016-2027)
6.2.2 North America Verapamil Revenue by Sales Channel (2016-2027)
6.3 North America Verapamil Market Size by Country
6.3.1 North America Verapamil Sales by Country (2016-2027)
6.3.2 North America Verapamil Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Verapamil Market Size by Type
7.1.1 Europe Verapamil Sales by Type (2016-2027)
7.1.2 Europe Verapamil Revenue by Type (2016-2027)
7.2 Europe Verapamil Market Size by Sales Channel
7.2.1 Europe Verapamil Sales by Sales Channel (2016-2027)
7.2.2 Europe Verapamil Revenue by Sales Channel (2016-2027)
7.3 Europe Verapamil Market Size by Country
7.3.1 Europe Verapamil Sales by Country (2016-2027)
7.3.2 Europe Verapamil Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Verapamil Market Size by Type
8.1.1 Asia Pacific Verapamil Sales by Type (2016-2027)
8.1.2 Asia Pacific Verapamil Revenue by Type (2016-2027)
8.2 Asia Pacific Verapamil Market Size by Sales Channel
8.2.1 Asia Pacific Verapamil Sales by Sales Channel (2016-2027)
8.2.2 Asia Pacific Verapamil Revenue by Sales Channel (2016-2027)
8.3 Asia Pacific Verapamil Market Size by Region
8.3.1 Asia Pacific Verapamil Sales by Region (2016-2027)
8.3.2 Asia Pacific Verapamil Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Verapamil Market Size by Type
9.1.1 Latin America Verapamil Sales by Type (2016-2027)
9.1.2 Latin America Verapamil Revenue by Type (2016-2027)
9.2 Latin America Verapamil Market Size by Sales Channel
9.2.1 Latin America Verapamil Sales by Sales Channel (2016-2027)
9.2.2 Latin America Verapamil Revenue by Sales Channel (2016-2027)
9.3 Latin America Verapamil Market Size by Country
9.3.1 Latin America Verapamil Sales by Country (2016-2027)
9.3.2 Latin America Verapamil Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Verapamil Market Size by Type
10.1.1 Middle East and Africa Verapamil Sales by Type (2016-2027)
10.1.2 Middle East and Africa Verapamil Revenue by Type (2016-2027)
10.2 Middle East and Africa Verapamil Market Size by Sales Channel
10.2.1 Middle East and Africa Verapamil Sales by Sales Channel (2016-2027)
10.2.2 Middle East and Africa Verapamil Revenue by Sales Channel (2016-2027)
10.3 Middle East and Africa Verapamil Market Size by Country
10.3.1 Middle East and Africa Verapamil Sales by Country (2016-2027)
10.3.2 Middle East and Africa Verapamil Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 REPLEK FARM
11.1.1 REPLEK FARM Corporation Information
11.1.2 REPLEK FARM Overview
11.1.3 REPLEK FARM Verapamil Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 REPLEK FARM Verapamil Product Description
11.1.5 REPLEK FARM Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Overview
11.2.3 Mylan Verapamil Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Mylan Verapamil Product Description
11.2.5 Mylan Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Overview
11.3.3 Abbott Laboratories Verapamil Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Abbott Laboratories Verapamil Product Description
11.3.5 Abbott Laboratories Recent Developments
11.4 YUNGSHIN PHARM IND. CO. LTD
11.4.1 YUNGSHIN PHARM IND. CO. LTD Corporation Information
11.4.2 YUNGSHIN PHARM IND. CO. LTD Overview
11.4.3 YUNGSHIN PHARM IND. CO. LTD Verapamil Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 YUNGSHIN PHARM IND. CO. LTD Verapamil Product Description
11.4.5 YUNGSHIN PHARM IND. CO. LTD Recent Developments
11.5 The Central Pharmaceutical CO.,Ltd.Tianjin
11.5.1 The Central Pharmaceutical CO.,Ltd.Tianjin Corporation Information
11.5.2 The Central Pharmaceutical CO.,Ltd.Tianjin Overview
11.5.3 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Description
11.5.5 The Central Pharmaceutical CO.,Ltd.Tianjin Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Verapamil Value Chain Analysis
12.2 Verapamil Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Verapamil Production Mode & Process
12.4 Verapamil Sales and Marketing
12.4.1 Verapamil Sales Channels
12.4.2 Verapamil Distributors
12.5 Verapamil Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Verapamil Industry Trends
13.2 Verapamil Market Drivers
13.3 Verapamil Market Challenges
13.4 Verapamil Market Restraints
14 Key Findings in The Global Verapamil Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Verapamil Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsules
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Others
Table 6. Global Verapamil Market Size Growth Rate by Sales Channel, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Verapamil Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Verapamil Sales by Region (2016-2021) & (K Units)
Table 9. Global Verapamil Sales Market Share by Region (2016-2021)
Table 10. Global Verapamil Sales by Region (2022-2027) & (K Units)
Table 11. Global Verapamil Sales Market Share by Region (2022-2027)
Table 12. Global Verapamil Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Verapamil Revenue Market Share by Region (2016-2021)
Table 14. Global Verapamil Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Verapamil Revenue Market Share by Region (2022-2027)
Table 16. Global Verapamil Sales by Manufacturers (2016-2021) & (K Units)
Table 17. Global Verapamil Sales Share by Manufacturers (2016-2021)
Table 18. Global Verapamil Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Verapamil Revenue Share by Manufacturers (2016-2021)
Table 20. Verapamil Price by Manufacturers 2016-2021 (US$/Unit)
Table 21. Global Verapamil Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Verapamil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Verapamil as of 2020)
Table 23. Verapamil Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Verapamil Product Offered
Table 25. Date of Manufacturers Enter into Verapamil Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Verapamil Sales by Type (2016-2021) & (K Units)
Table 28. Global Verapamil Sales by Type (2022-2027) & (K Units)
Table 29. Global Verapamil Sales Share by Type (2016-2021)
Table 30. Global Verapamil Sales Share by Type (2022-2027)
Table 31. Global Verapamil Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Verapamil Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Verapamil Revenue Share by Type (2016-2021)
Table 34. Global Verapamil Revenue Share by Type (2022-2027)
Table 35. Verapamil Price by Type (2016-2021) & (US$/Unit)
Table 36. Global Verapamil Price Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Verapamil Sales by Sales Channel (2016-2021) & (K Units)
Table 38. Global Verapamil Sales by Sales Channel (2022-2027) & (K Units)
Table 39. Global Verapamil Sales Share by Sales Channel (2016-2021)
Table 40. Global Verapamil Sales Share by Sales Channel (2022-2027)
Table 41. Global Verapamil Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 42. Global Verapamil Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 43. Global Verapamil Revenue Share by Sales Channel (2016-2021)
Table 44. Global Verapamil Revenue Share by Sales Channel (2022-2027)
Table 45. Verapamil Price by Sales Channel (2016-2021) & (US$/Unit)
Table 46. Global Verapamil Price Forecast by Sales Channel (2022-2027) & (US$/Unit)
Table 47. North America Verapamil Sales by Type (2016-2021) & (K Units)
Table 48. North America Verapamil Sales by Type (2022-2027) & (K Units)
Table 49. North America Verapamil Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Verapamil Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Verapamil Sales by Sales Channel (2016-2021) & (K Units)
Table 52. North America Verapamil Sales by Sales Channel (2022-2027) & (K Units)
Table 53. North America Verapamil Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 54. North America Verapamil Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 55. North America Verapamil Sales by Country (2016-2021) & (K Units)
Table 56. North America Verapamil Sales by Country (2022-2027) & (K Units)
Table 57. North America Verapamil Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Verapamil Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Verapamil Sales by Type (2016-2021) & (K Units)
Table 60. Europe Verapamil Sales by Type (2022-2027) & (K Units)
Table 61. Europe Verapamil Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Verapamil Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Verapamil Sales by Sales Channel (2016-2021) & (K Units)
Table 64. Europe Verapamil Sales by Sales Channel (2022-2027) & (K Units)
Table 65. Europe Verapamil Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 66. Europe Verapamil Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 67. Europe Verapamil Sales by Country (2016-2021) & (K Units)
Table 68. Europe Verapamil Sales by Country (2022-2027) & (K Units)
Table 69. Europe Verapamil Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Verapamil Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Verapamil Sales by Type (2016-2021) & (K Units)
Table 72. Asia Pacific Verapamil Sales by Type (2022-2027) & (K Units)
Table 73. Asia Pacific Verapamil Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Verapamil Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Verapamil Sales by Sales Channel (2016-2021) & (K Units)
Table 76. Asia Pacific Verapamil Sales by Sales Channel (2022-2027) & (K Units)
Table 77. Asia Pacific Verapamil Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 78. Asia Pacific Verapamil Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 79. Asia Pacific Verapamil Sales by Region (2016-2021) & (K Units)
Table 80. Asia Pacific Verapamil Sales by Region (2022-2027) & (K Units)
Table 81. Asia Pacific Verapamil Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Verapamil Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Verapamil Sales by Type (2016-2021) & (K Units)
Table 84. Latin America Verapamil Sales by Type (2022-2027) & (K Units)
Table 85. Latin America Verapamil Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Verapamil Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Verapamil Sales by Sales Channel (2016-2021) & (K Units)
Table 88. Latin America Verapamil Sales by Sales Channel (2022-2027) & (K Units)
Table 89. Latin America Verapamil Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 90. Latin America Verapamil Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 91. Latin America Verapamil Sales by Country (2016-2021) & (K Units)
Table 92. Latin America Verapamil Sales by Country (2022-2027) & (K Units)
Table 93. Latin America Verapamil Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Verapamil Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Verapamil Sales by Type (2016-2021) & (K Units)
Table 96. Middle East and Africa Verapamil Sales by Type (2022-2027) & (K Units)
Table 97. Middle East and Africa Verapamil Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Verapamil Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Verapamil Sales by Sales Channel (2016-2021) & (K Units)
Table 100. Middle East and Africa Verapamil Sales by Sales Channel (2022-2027) & (K Units)
Table 101. Middle East and Africa Verapamil Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Verapamil Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Verapamil Sales by Country (2016-2021) & (K Units)
Table 104. Middle East and Africa Verapamil Sales by Country (2022-2027) & (K Units)
Table 105. Middle East and Africa Verapamil Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Verapamil Revenue by Country (2022-2027) & (US$ Million)
Table 107. REPLEK FARM Corporation Information
Table 108. REPLEK FARM Description and Major Businesses
Table 109. REPLEK FARM Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. REPLEK FARM Verapamil Product
Table 111. REPLEK FARM Recent Developments
Table 112. Mylan Corporation Information
Table 113. Mylan Description and Major Businesses
Table 114. Mylan Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Mylan Verapamil Product
Table 116. Mylan Recent Developments
Table 117. Abbott Laboratories Corporation Information
Table 118. Abbott Laboratories Description and Major Businesses
Table 119. Abbott Laboratories Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Abbott Laboratories Verapamil Product
Table 121. Abbott Laboratories Recent Developments
Table 122. YUNGSHIN PHARM IND. CO. LTD Corporation Information
Table 123. YUNGSHIN PHARM IND. CO. LTD Description and Major Businesses
Table 124. YUNGSHIN PHARM IND. CO. LTD Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. YUNGSHIN PHARM IND. CO. LTD Verapamil Product
Table 126. YUNGSHIN PHARM IND. CO. LTD Recent Developments
Table 127. The Central Pharmaceutical CO.,Ltd.Tianjin Corporation Information
Table 128. The Central Pharmaceutical CO.,Ltd.Tianjin Description and Major Businesses
Table 129. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product
Table 131. The Central Pharmaceutical CO.,Ltd.Tianjin Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Verapamil Distributors List
Table 135. Verapamil Customers List
Table 136. Verapamil Market Trends
Table 137. Verapamil Market Drivers
Table 138. Verapamil Market Challenges
Table 139. Verapamil Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Verapamil Product Picture
Figure 2. Global Verapamil Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Capsules Product Picture
Figure 5. Injection Product Picture
Figure 6. Others Product Picture
Figure 7. Global Verapamil Market Share by Sales Channel in 2020 & 2027
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Sales
Figure 11. Others
Figure 12. Verapamil Report Years Considered
Figure 13. Global Verapamil Sales 2016-2027 (K Units)
Figure 14. Global Verapamil Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Verapamil Revenue 2016-2027 (US$ Million)
Figure 16. Global Verapamil Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Verapamil Sales Market Share by Region (2016-2021)
Figure 18. Global Verapamil Sales Market Share by Region (2022-2027)
Figure 19. North America Verapamil Sales YoY (2016-2027) & (K Units)
Figure 20. North America Verapamil Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Verapamil Sales YoY (2016-2027) & (K Units)
Figure 22. Europe Verapamil Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Verapamil Sales YoY (2016-2027) & (K Units)
Figure 24. Asia-Pacific Verapamil Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Verapamil Sales YoY (2016-2027) & (K Units)
Figure 26. Latin America Verapamil Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Verapamil Sales YoY (2016-2027) & (K Units)
Figure 28. Middle East & Africa Verapamil Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Verapamil Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Verapamil Revenue in 2020
Figure 31. Verapamil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Verapamil Sales Market Share by Type (2016-2027)
Figure 33. Global Verapamil Revenue Market Share by Type (2016-2027)
Figure 34. Global Verapamil Sales Market Share by Sales Channel (2016-2027)
Figure 35. Global Verapamil Revenue Market Share by Sales Channel (2016-2027)
Figure 36. North America Verapamil Sales Market Share by Type (2016-2027)
Figure 37. North America Verapamil Revenue Market Share by Type (2016-2027)
Figure 38. North America Verapamil Sales Market Share by Sales Channel (2016-2027)
Figure 39. North America Verapamil Revenue Market Share by Sales Channel (2016-2027)
Figure 40. North America Verapamil Sales Share by Country (2016-2027)
Figure 41. North America Verapamil Revenue Share by Country (2016-2027)
Figure 42. United States Verapamil Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Verapamil Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Verapamil Sales Market Share by Type (2016-2027)
Figure 45. Europe Verapamil Revenue Market Share by Type (2016-2027)
Figure 46. Europe Verapamil Sales Market Share by Sales Channel (2016-2027)
Figure 47. Europe Verapamil Revenue Market Share by Sales Channel (2016-2027)
Figure 48. Europe Verapamil Sales Share by Country (2016-2027)
Figure 49. Europe Verapamil Revenue Share by Country (2016-2027)
Figure 50. Germany Verapamil Revenue (2016-2027) & (US$ Million)
Figure 51. France Verapamil Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Verapamil Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Verapamil Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Verapamil Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Verapamil Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Verapamil Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Verapamil Sales Market Share by Sales Channel (2016-2027)
Figure 58. Asia Pacific Verapamil Revenue Market Share by Sales Channel (2016-2027)
Figure 59. Asia Pacific Verapamil Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Verapamil Revenue Share by Region (2016-2027)
Figure 61. China Verapamil Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Verapamil Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Verapamil Revenue (2016-2027) & (US$ Million)
Figure 64. India Verapamil Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Verapamil Revenue (2016-2027) & (US$ Million)
Figure 66. China Taiwan Verapamil Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Verapamil Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Verapamil Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Verapamil Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Verapamil Sales Market Share by Type (2016-2027)
Figure 71. Latin America Verapamil Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Verapamil Sales Market Share by Sales Channel (2016-2027)
Figure 73. Latin America Verapamil Revenue Market Share by Sales Channel (2016-2027)
Figure 74. Latin America Verapamil Sales Share by Country (2016-2027)
Figure 75. Latin America Verapamil Revenue Share by Country (2016-2027)
Figure 76. Mexico Verapamil Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Verapamil Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Verapamil Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Verapamil Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Verapamil Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Verapamil Sales Market Share by Sales Channel (2016-2027)
Figure 82. Middle East and Africa Verapamil Revenue Market Share by Sales Channel (2016-2027)
Figure 83. Middle East and Africa Verapamil Sales Share by Country (2016-2027)
Figure 84. Middle East and Africa Verapamil Revenue Share by Country (2016-2027)
Figure 85. Turkey Verapamil Revenue (2016-2027) & (US$ Million)
Figure 86. Saudi Arabia Verapamil Revenue (2016-2027) & (US$ Million)
Figure 87. UAE Verapamil Revenue (2016-2027) & (US$ Million)
Figure 88. Verapamil Value Chain
Figure 89. Verapamil Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
世界のマルチビタミンカプセル＆錠剤市場インサイト・予測（～2027年） Multivitamins are a combination of different vitamins and minerals present in food sources. Consumption of multivitamins daily can help us to make up for nutritional gaps to boost our health naturally. Multivitamins are an instant way to fulfil our everyday demands of nutrition and to get our daily …- 薬局自動化システムの世界及び中国市場 Pharmacy Automation is the mechanization or automation of tasks and processes performed in pharmacy or other health care settings. It includes process like medication dispensing, packaging, labeling, storage and retrieval systems and table top counters. The pharmacy automation not only streamline ph…
- 薬局自動化用装置の世界及び中国市場 Pharmacy automation refers to the mechanization and informationization of all drugs from management to final delivery to patients after they enter the hospital. From the perspective of product type and technology, the main types of products in the global pharmacy automation equipment market are auto…
- 病院及び薬局用ロボットの世界市場 2020年 Market Overview The global Hospital and Pharmacy Robotics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospital and P…
- 世界のソラフェニブトシル酸塩錠市場インサイト・予測（～2027年） Sorafenib tosylate Tablets are used as clinical anticancer agents for the treatment of liver and renal cell carcinoma. Market Analysis and Insights: Global Sorafenib Tosylate Tablets Market The global Sorafenib Tosylate Tablets market is valued at US$ XX million in 2020. The market size will reach U…